Advertisement

Ads Placeholder
Loading...

Panacea Biotec Limited

PANACEABIO.BO•BSE
Healthcare
Biotechnology
₹322.90
₹-1.75(-0.54%)
Indian Market opens in 34h 48m

Panacea Biotec Limited (PANACEABIO.BO) Stock Overview

Explore Panacea Biotec Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.8B
P/E Ratio-254.61
EPS (TTM)$-1.27
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$415.89
3 Months$475.77
1 Year Target$626.97

PANACEABIO.BO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Panacea Biotec Limited (PANACEABIO.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $626.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -254.61 and a market capitalization of 19.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.54%
5-Day Change
-1.72%
1-Month Change
1.14%
3-Month Change
-15.22%
6-Month Change
-22.25%
Year-to-Date (YTD) Change
-14.58%
1-Year Change
-30.74%
3-Year Change
83.88%
5-Year Change
83.88%
All-Time (Max) Change
83.88%

Contact Information

https://www.panaceabiotec.com
91 11 4167 9000
B-1 Extension/G-3, New Delhi, NaN, 110044

Company Facts

19,360 Employees
IPO DateFeb 5, 2003
CountryIN
Actively Trading

Frequently Asked Questions